-
Something wrong with this record ?
Ciguatoxins Evoke Potent CGRP Release by Activation of Voltage-Gated Sodium Channel Subtypes NaV1.9, NaV1.7 and NaV1.1
F. Touska, S. Sattler, P. Malsch, RJ. Lewis, PW. Reeh, K. Zimmermann,
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2003
Free Medical Journals
from 2003
PubMed Central
from 2003
Europe PubMed Central
from 2003
ProQuest Central
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Health & Medicine (ProQuest)
from 2003-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2003
PubMed
28867800
DOI
10.3390/md15090269
Knihovny.cz E-resources
- MeSH
- Ciguatera Poisoning metabolism MeSH
- Ciguatoxins chemistry pharmacology MeSH
- Enzyme-Linked Immunosorbent Assay MeSH
- Hyperalgesia chemically induced MeSH
- Rats MeSH
- Humans MeSH
- Lidocaine pharmacology MeSH
- Membrane Potentials drug effects MeSH
- Marine Toxins pharmacology MeSH
- Mice, Transgenic MeSH
- Mice MeSH
- NAV1.1 Voltage-Gated Sodium Channel drug effects MeSH
- NAV1.9 Voltage-Gated Sodium Channel drug effects MeSH
- NAV1.7 Voltage-Gated Sodium Channel drug effects MeSH
- Calcitonin Gene-Related Peptide drug effects MeSH
- Receptors, Calcitonin Gene-Related Peptide drug effects MeSH
- Tetrodotoxin pharmacology MeSH
- Calcium metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Ciguatoxins (CTXs) are marine toxins that cause ciguatera fish poisoning, a debilitating disease dominated by sensory and neurological disturbances that include cold allodynia and various painful symptoms as well as long-lasting pruritus. Although CTXs are known as the most potent mammalian sodium channel activator toxins, the etiology of many of its neurosensory symptoms remains unresolved. We recently described that local application of 1 nM Pacific Ciguatoxin-1 (P-CTX-1) into the skin of human subjects induces a long-lasting, painful axon reflex flare and that CTXs are particularly effective in releasing calcitonin-gene related peptide (CGRP) from nerve terminals. In this study, we used mouse and rat skin preparations and enzyme-linked immunosorbent assays (ELISA) to study the molecular mechanism by which P-CTX-1 induces CGRP release. We show that P-CTX-1 induces CGRP release more effectively in mouse as compared to rat skin, exhibiting EC50 concentrations in the low nanomolar range. P-CTX-1-induced CGRP release from skin is dependent on extracellular calcium and sodium, but independent from the activation of various thermosensory transient receptor potential (TRP) ion channels. In contrast, lidocaine and tetrodotoxin (TTX) reduce CGRP release by 53-75%, with the remaining fraction involving L-type and T-type voltage-gated calcium channels (VGCC). Using transgenic mice, we revealed that the TTX-resistant voltage-gated sodium channel (VGSC) NaV1.9, but not NaV1.8 or NaV1.7 alone and the combined activation of the TTX-sensitive VGSC subtypes NaV1.7 and NaV1.1 carry the largest part of the P-CTX-1-caused CGRP release of 42% and 34%, respectively. Given the contribution of CGRP to nociceptive and itch sensing pathways, our findings contribute to a better understanding of sensory symptoms of acute and chronic ciguatera that may help in the identification of potential therapeutics.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024684
- 003
- CZ-PrNML
- 005
- 20231002114411.0
- 007
- ta
- 008
- 180709s2017 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/md15090269 $2 doi
- 035 __
- $a (PubMed)28867800
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Touska, Filip $u Department of Anesthesiology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital Erlangen, Krankenhausstraße 12, 91054 Erlangen, Germany. touska@biomed.cas.cz. Department of Cellular Neurophysiology, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague 4, Czech Republic. touska@biomed.cas.cz.
- 245 10
- $a Ciguatoxins Evoke Potent CGRP Release by Activation of Voltage-Gated Sodium Channel Subtypes NaV1.9, NaV1.7 and NaV1.1 / $c F. Touska, S. Sattler, P. Malsch, RJ. Lewis, PW. Reeh, K. Zimmermann,
- 520 9_
- $a Ciguatoxins (CTXs) are marine toxins that cause ciguatera fish poisoning, a debilitating disease dominated by sensory and neurological disturbances that include cold allodynia and various painful symptoms as well as long-lasting pruritus. Although CTXs are known as the most potent mammalian sodium channel activator toxins, the etiology of many of its neurosensory symptoms remains unresolved. We recently described that local application of 1 nM Pacific Ciguatoxin-1 (P-CTX-1) into the skin of human subjects induces a long-lasting, painful axon reflex flare and that CTXs are particularly effective in releasing calcitonin-gene related peptide (CGRP) from nerve terminals. In this study, we used mouse and rat skin preparations and enzyme-linked immunosorbent assays (ELISA) to study the molecular mechanism by which P-CTX-1 induces CGRP release. We show that P-CTX-1 induces CGRP release more effectively in mouse as compared to rat skin, exhibiting EC50 concentrations in the low nanomolar range. P-CTX-1-induced CGRP release from skin is dependent on extracellular calcium and sodium, but independent from the activation of various thermosensory transient receptor potential (TRP) ion channels. In contrast, lidocaine and tetrodotoxin (TTX) reduce CGRP release by 53-75%, with the remaining fraction involving L-type and T-type voltage-gated calcium channels (VGCC). Using transgenic mice, we revealed that the TTX-resistant voltage-gated sodium channel (VGSC) NaV1.9, but not NaV1.8 or NaV1.7 alone and the combined activation of the TTX-sensitive VGSC subtypes NaV1.7 and NaV1.1 carry the largest part of the P-CTX-1-caused CGRP release of 42% and 34%, respectively. Given the contribution of CGRP to nociceptive and itch sensing pathways, our findings contribute to a better understanding of sensory symptoms of acute and chronic ciguatera that may help in the identification of potential therapeutics.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a peptid spojený s genem pro kalcitonin $x účinky léků $7 D015740
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a ciguatera $x metabolismus $7 D036841
- 650 _2
- $a ciguatoxiny $x chemie $x farmakologie $7 D002922
- 650 _2
- $a ELISA $7 D004797
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperalgezie $x chemicky indukované $7 D006930
- 650 _2
- $a lidokain $x farmakologie $7 D008012
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mořské toxiny $x farmakologie $7 D008387
- 650 _2
- $a membránové potenciály $x účinky léků $7 D008564
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši transgenní $7 D008822
- 650 _2
- $a napětím řízený sodíkový kanál, typ 1 $x účinky léků $7 D062550
- 650 _2
- $a napěťově řízený sodíkový kanál, typ 9 $x účinky léků $7 D062556
- 650 _2
- $a napětově řízený sodíkový kanál typ 11 $x účinky léků $7 D062558
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a receptory peptidu se vztahem ke genu kalcitoninu $x účinky léků $7 D018015
- 650 _2
- $a tetrodotoxin $x farmakologie $7 D013779
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sattler, Simon $u Department of Physiology and Pathophysiology, Friedrich-Alexander-University Erlangen-Nuremberg, Universitätsstraße 17, 91054 Erlangen, Germany. simon.sattler@outlook.com.
- 700 1_
- $a Malsch, Philipp $u Department of Physiology and Pathophysiology, Friedrich-Alexander-University Erlangen-Nuremberg, Universitätsstraße 17, 91054 Erlangen, Germany. philippmalsch@googlemail.com.
- 700 1_
- $a Lewis, Richard J., $u Institute for Molecular Biosciences, IMB Centre for Pain Research, University of Queensland, 4072 St Lucia, Australia. r.lewis@uq.edu.au. $d 1957- $7 xx0250433
- 700 1_
- $a Reeh, Peter W $u Department of Physiology and Pathophysiology, Friedrich-Alexander-University Erlangen-Nuremberg, Universitätsstraße 17, 91054 Erlangen, Germany. peter.reeh@fau.de.
- 700 1_
- $a Zimmermann, Katharina $u Department of Anesthesiology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital Erlangen, Krankenhausstraße 12, 91054 Erlangen, Germany. katharina.zimmermann@fau.de.
- 773 0_
- $w MED00165871 $t Marine drugs $x 1660-3397 $g Roč. 15, č. 9 (2017)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28867800 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20231002114409 $b ABA008
- 999 __
- $a ok $b bmc $g 1316815 $s 1021605
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 15 $c 9 $e 20170830 $i 1660-3397 $m Marine drugs $n Mar. drugs $x MED00165871
- LZP __
- $a Pubmed-20180709